Dr. Steven E. Suter, VMD, MS, PhD, DACVIM
Diplomate, American College of Veterinary Internal Medicine (Oncology)
Doctor of Philosophy, Molecular Biology, University of Pennsylvania
Master of Science, Biochemistry, New York Medical College
Doctor of Veterinary Medicine, University of Pennsylvania
Molecular oncology; Development of novel therapeutics
Professional Experience & Qualifications
July 2012-present: Associate Professor of Oncology, North Carolina State University, College of Veterinary Medicine, Department of Clinical Sciences, Raleigh, NC
January 2006-June 2012: Assistant Professor of Oncology, North Carolina State University, College of Veterinary Medicine, Department of Clinical Sciences, Raleigh, NC
June 2005-December 2005: Medical Oncologist, Sacramento Animal Medical Group, Sacramento, CA
August 2003-June 2005: Lecturer, Medical Oncology, University of California, Davis, Veterinary Medical Teaching Hospital, Davis, CA
August 2001-July 2003: Resident, Medical Oncology, University of California, Davis, Veterinary Medical Teaching Hospital, Davis, CA
July 2000-July 2001: Intern, Small Animal Medicine and Surgery, University of Pennsylvania, Mathew J. Ryan Veterinary Teaching Hospital, Philadelphia, PA
Canine and feline lymphoma
Aberrant gene expression
Novel therapeutics to treat cancer
Autologous peripheral blood hematopoietic cell transplantation in dogs with B-cell lymphoma. Willcox JL, Pruitt A, Suter SE. J Vet Intern Med Sept-Oct;26(5): 1155-63, 2012.
Hematologic changes after total body irradiation and autologous transplantation of hematopoietic peripheral blood progenitor cells in dogs with lymphoma. Escobar G, Grindem C, Neel JA, Suter SE. Vet Pathol Mar;49(2): 341-3, 2012.
Collection of peripheral blood CD34+ progenitor cells from healthy dogs and dogs diagnosed with lymphoproliferative diseases using a Baxter-Fenwal CS-3000 Plus blood cell separator. Suter SE. J Vet Intern Med Nov-Dec;25(6): 1406-13, 2011.
FLT3 mutations in canine acute lymphocytic leukemia. Suter SE, Small GW, Seiser EL, Thomas R, Breen M, Richards KL. BMC Cancer Jan 27;11:38, 2011.
Soy derived isoflavones inhibit the growth of canine lymphoid cell lines. Jamadar-Shroff V, Papich M, Suter SE. Clin Can Research 15;4(Feb 15): 1269-1275, 2009.
Immunophenotypic and cytomorphologic subclassification of T-cell lymphoma in the boxer breed. Lurie DM, Milner RJ, Suter SE, Vernau W. Vet Immunol Immunopathol. 125: 102-110, 2008.
Obesity prevalence in dogs with cancer: 1999-2004. Weeth LP, Fascetti AJ, Kass PH, Suter SE, Santos AM, Delaney SJ. Am J Vet Res Apr;68(4):389-98, 2007.
Marking of peripheral T-lymphocytes by retroviral transduction and transplantation of CD34+ cells in a canine X-linked severe combined immunodeficiency model. Suter SE, Hartnett BE, Gouthro TA, McSweeney PA, Nash RA, Felsburg PJ, Haskins ME, Henthorn PS. Vet Immunol Immunopathol 117:183-196, 2007.
Transduction of ennriched populations of paediatric canine CD34+ cells using an MSCV- based bicistronic vector. Suter SE, Gouthro TA, McSweeney PA, Nash RA, Haskins ME, Felsburg PJ, Henthorn PS. Vet Res Comm 30:881-901, 2006.
Canine distemper virus infection of canine lymphoid cells: A prelude to oncolytic therapy for lymphoma. Suter SE, Madewell BR, Chein MB, von Messling V, Yip, B, Cattaneo, RB, London, CA. Clin Cancer Res. Feb 15;11(4):1579-87, 2005.
Isolation and characterization of pediatric canine bone marrow CD34+ Cells. Suter SE, Gouthro TA, McSweeney PA, Nash RA, Haskins ME, Felsburg PJ, Henthorn PS. Vet Immunol Immunopathol. Sep;101(1-2):31-47, 2004.
Transplantation of X-linked severe combined immunodeficient dogs with CD34+ bone marrow cells. Hartnett BJ, Yao D, Suter SE, Ellinwood NM, Henthorn PS, Moore PE, McSweeney PA, Nash RA, Brown JD, Weinberg KI, Felsberg PJ. Biol Blood Marrow Transplant 8(4):188-97, 2002.
Bone Marrow Transplantation (BMT) of X-SCID dogs with d c chain heterozygous bone marrow cells. Hartnett BJ, Suter SE, Henthorn PE, Weinberg KI, Moore PF, Ochs HD, and Felsburg PJ. J Allergy and Immuno V0099:414 N:P255, 1997.
Full immunological reconstitution following non-conditional bone marrow transplantation for canine X-linked secure combined immunodeficiency. Felsburg PF, Somberg RL, Hartnett BJ, Suter SE , Henthorn PS, Moore PF, Weinberg KI, Ochs HP. Blood 90:3212-3221, 1997.